AAAAAA

   
Results: 1-8 |
Results: 8
COMPARATIVE EFFICACY OF INTRAVENOUS PROPAFENONE AND PROCAINAMIDE IN PATIENTS WITH PAROXYSMAL ATRIAL-FIBRILLATION - RANDOMIZED PLACEBO-CONTROLLED BLIND-STUDY
Authors: KANORSKY SG SKIBITSKY VV
Citation: Sg. Kanorsky et Vv. Skibitsky, COMPARATIVE EFFICACY OF INTRAVENOUS PROPAFENONE AND PROCAINAMIDE IN PATIENTS WITH PAROXYSMAL ATRIAL-FIBRILLATION - RANDOMIZED PLACEBO-CONTROLLED BLIND-STUDY, Kardiologia, 38(9), 1998, pp. 42-46
TALINOLOL OF PROLONGED ACTION - CORDANUM-100 - IN THE TREATMENT OF ESSENTIAL-HYPERTENSION AND ISCHEMIC-HEART-DISEASE - COMPARISON TO PROPRANOLOL
Authors: SKIBITSKY VV KANORSKY SG
Citation: Vv. Skibitsky et Sg. Kanorsky, TALINOLOL OF PROLONGED ACTION - CORDANUM-100 - IN THE TREATMENT OF ESSENTIAL-HYPERTENSION AND ISCHEMIC-HEART-DISEASE - COMPARISON TO PROPRANOLOL, Kardiologia, 38(7), 1998, pp. 4-6
CORRECTION OF STRUCTURAL-CHANGES OF THE L EFT-HEART IN PATIENTS WITH EFFECTIVE PREVENTIVE TREATMENT OF RECURRENT ATTACKS OF PAROXYSMAL ATRIAL-FIBRILLATION
Authors: KANORSKY SG SKIBITSKY VV FEDOROV AV
Citation: Sg. Kanorsky et al., CORRECTION OF STRUCTURAL-CHANGES OF THE L EFT-HEART IN PATIENTS WITH EFFECTIVE PREVENTIVE TREATMENT OF RECURRENT ATTACKS OF PAROXYSMAL ATRIAL-FIBRILLATION, Kardiologia, 38(2), 1998, pp. 37-42
NEW POSSIBILITIES OF ASSESSMENT OF PREVEN TIVE EFFICACY OF ANTIARRHYTHMIC DRUGS IN PATIENTS WITH PAROXYSMAL ATRIAL-FIBRILLATION
Authors: KANORSKY SG SKIBITSKY VV KUDRYASHOV EA
Citation: Sg. Kanorsky et al., NEW POSSIBILITIES OF ASSESSMENT OF PREVEN TIVE EFFICACY OF ANTIARRHYTHMIC DRUGS IN PATIENTS WITH PAROXYSMAL ATRIAL-FIBRILLATION, Kardiologia, 37(3), 1997, pp. 42-46
EFFICACY AND SAFETY OF DIFFERENTIATED PHA RMACOLOGICAL PREVENTION OF ATTACKS OF ATRIAL-FIBRILLATION
Authors: KANORSKY SG SKIBITSKY VV FEDOROV AV
Citation: Sg. Kanorsky et al., EFFICACY AND SAFETY OF DIFFERENTIATED PHA RMACOLOGICAL PREVENTION OF ATTACKS OF ATRIAL-FIBRILLATION, Kardiologia, 37(12), 1997, pp. 65-66
NEUROPHARMACEUTICAL ANALYSIS OF CARDIOVAS CULAR EFFECTS OF GIDAZEPAM IN PATIENTS WITH NEUROCIRCULATORY DYSTONIA AND VENTRICULAR ARRHYTHMIAS
Authors: SKRIBITSKY VV PETROVA TP TATARKIN AN KANORSKY SG
Citation: Vv. Skribitsky et al., NEUROPHARMACEUTICAL ANALYSIS OF CARDIOVAS CULAR EFFECTS OF GIDAZEPAM IN PATIENTS WITH NEUROCIRCULATORY DYSTONIA AND VENTRICULAR ARRHYTHMIAS, Kardiologia, 34(1-2), 1994, pp. 153-155
RESULTS OF ACUTE DRUG-TESTING AND COURSE TREATMENT WITH ACTIVATORS OFTHE GAMAERGIC STRESS-LIMITING SYSTEM IN PATIENTS WITH CARDIAC-ARRHYTHMIAS
Authors: SKIBITSKY VV KANORSKY SG
Citation: Vv. Skibitsky et Sg. Kanorsky, RESULTS OF ACUTE DRUG-TESTING AND COURSE TREATMENT WITH ACTIVATORS OFTHE GAMAERGIC STRESS-LIMITING SYSTEM IN PATIENTS WITH CARDIAC-ARRHYTHMIAS, Kardiologia, 33(6), 1993, pp. 45-49
COMPARATIVE-ANALYSIS OF THE ANTIARRHYTHMI C ACTION AND ELECTROPHYSIOLOGICAL EFFECTS OF THE NEW BENZODIAZEPIN DERIVATIVE GIDAZEPAM AND ETHACIZINE IN CARDIAC-ARRHYTHMIAS OF VARIOUS GENESIS
Authors: SKIBITSKY VV PETROVA TR KANORSKY SG
Citation: Vv. Skibitsky et al., COMPARATIVE-ANALYSIS OF THE ANTIARRHYTHMI C ACTION AND ELECTROPHYSIOLOGICAL EFFECTS OF THE NEW BENZODIAZEPIN DERIVATIVE GIDAZEPAM AND ETHACIZINE IN CARDIAC-ARRHYTHMIAS OF VARIOUS GENESIS, Kardiologia, 32(6), 1992, pp. 35-37
Risultati: 1-8 |